Pfizer Shares Fall as 2026 Outlook Reflects Weaker COVID-19 Drug Demand
Pfizer shares fell after the company issued weaker-than-expected 2026 guidance, citing lower demand for COVID-19 products and upcoming patent expirations.The post Pfizer Shares Fall as 2026 Outlook Reflects Weaker COVID-19 Drug Demand appeared first on Tokenist.